icic 2014 the future of pharmaceutical and life science publishing industries

Life Sciences, The Contentverse and Publishing

Duncan Fraser

Director, Pharmaceutical & Biotech Markets

Life, Universe & Everything ICIC | 10/15/2014 | 2

A bit about me

• Biological Sciences background

• 22 years in “the Industry”

• Bookselling – Waterstone’s

• University Library – Edinburgh Univ

• STM Book Production – Taylor & Francis

• Society Publishing – BVA

• Medical education editorial – Elsevier

• Product management for MedEd, A&D/Oil&Gas & Biomedical – Elsevier, IHS, BioMed Central

• Market & Product Strategy Pharma/Biotech – Springer

Life Sciences…


Changing strategies

• Originator examining their strategies post the 2012 patent cliff; R&D strategies are becoming more focussed

• Outsourcing is on the increase

• Generics

• Winning business models are being extended

• Expertise is being developed in key drug categories and/or therapeutic areas

• M&A activity is being used to strengthen leading positions


Total Shareholder Return over past 20 years


Leading a segment indicates increased profitability


Pharma on the move

• Pfizer & AZ – shelved (?)

• GSK & Novartis – Strengthened GSK in vaccines, Novartis shored up it’s 2nd place in oncology, joint venture in OTC puts them ahead of J&J

• AbbVie & Shire – Tax inversion benefit for AbbVie plus acquistion of Shire’s portfolio

• Bayer & Merck & Co. – Now 2nd in OTC plus stronger position in cardiology

• Including budgets – from the library direct to Research and Development departments, Libraries shifting from collection curation to strategic information delivery including competitive intelligence


Internal challenges

Regulatory burdens

Dealing with

processes

Dealing with

people

Dealing with information

ENVIRONMENTAL ORGANISATIONAL

Market economy and competition

within the industry


Non-information-related challenges are considerable

• Industry is moving at a fast pace, restructuring globally (e.g. offshoring, consolidation, highly competitive)

• Hard to identify what to focus on (e.g. what targets, how to differentiate) and new ways to do things (e.g. in science)

Competition within the industry

• Growing compliance issues with big hurdles to jump and increasingly comprehensive legislation

• Heavy reporting requirements

Regulatory burdens

• Making the case internally for more resources or for their ROI

• The bureaucracy to get things done in large companies

• Global time differences and lack of control

Dealing with internal

processes

• Identifying and helping interdisciplinary teams work together

• Finding out what colleagues really need Dealing with

people


Information-related challenges

• Filtering out the less relevant results from a search or from the alerts they receive

Noise

• Targeting the info they are really interested in

• Getting an overview of a new area Selectivity

• Staying up to date with the developments in their field

Currency

• Assessing the quality and accuracy or information Quality

• Lack of standardisation and comparability between database searches and outputs

Interoperability

• Pulling this all together; digesting and collating it

• Producing an easy to understand analysis Synthesis


Just in Case Just Enough Just In

Time

Just for Me

Changing user needs

…The Contentverse…


Big Data


Big Content

“The number of research papers published yearly shows a staggering exponential growth. One can in fact witness a century-long publication avalanche...

According to the two major databases INSPEC and Thomson Reuters, there is a 300-fold increase in the

number of published items since the year 1900…”

Confined to grow? Publication dynamics and the proliferation of scientific journals

Europhysics News 45/1, 2014, p. 19–22

http://dx.doi.org/10.1051/epn/2014102

http://dx.doi.org/10.1051/epn/2014102


What can be done to improve?


Unmet information needs?

Can you predict the future? I think we all get too much

information being thrown

at us all the time!

…and Publishing.


What’s the answer for Pharma?

A. More content

B. Less content

C. Focussed content

D. Content management tools

E. All of the above


Just in Case Just Enough Just In

Time Just for

Me

Back to this again


All of the above

• Analysis

• Thought leadership/opinion on what is important and why

• Flexibility

• More content, better positioned for those who want it

• Less content, focussed on specific areas or interest

• Enriched content

• Improved discovery

• Improved search functionality and results delivery

• Improved browse by creating more meaningful relationships between content sets

• Driving deeper engagement

• Get out of the way

• Data and text mining tools


Thank you

Duncan Fraser Director, Pharmaceutical & Biotech Markets

---

Springer Science + Business Media 236 Gray’s Inn Road | London WC1X 8HB | UK

[email protected]

@duncfrase

mailto:[email protected]







icic 2014 the future of pharmaceutical and life science publishing industries

Internet